XNCR has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
XNCR has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Xencor has the Financial Strength Rank of 6.
GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is rated on a scale of 1 to 10 and is based on these factors:
1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.A higher score indicates a stronger financial position, with companies rated 7 or above considered financially stable and unlikely to face distress. Conversely, a score of 3 or below suggests potential financial difficulties, indicating a higher risk of distress.
Xencor did not have earnings to cover the interest expense. Xencor's debt to revenue ratio for the quarter that ended in Dec. 2024 was 1.10. As of today, Xencor's Altman Z-Score is 0.31.
For the Biotechnology subindustry, Xencor's Financial Strength, along with its competitors' market caps and Financial Strength data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, Xencor's Financial Strength distribution charts can be found below:
* The bar in red indicates where Xencor's Financial Strength falls into.
GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.
Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
Xencor's Interest Expense for the months ended in Dec. 2024 was $-8.7 Mil. Its Operating Income for the months ended in Dec. 2024 was $-13.2 Mil. And its Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was $180.5 Mil.
Xencor's Interest Coverage for the quarter that ended in Dec. 2024 is
Xencor did not have earnings to cover the interest expense. |
The higher the ratio, the stronger the company's financial strength is.
2. Debt to revenue ratio. The lower, the better.
Xencor's Debt to Revenue Ratio for the quarter that ended in Dec. 2024 is
Debt to Revenue Ratio | = | Total Debt (Q: Dec. 2024 ) | / | Revenue | ||
= | (Short-Term Debt & Capital Lease Obligation | + | Long-Term Debt & Capital Lease Obligation) | / | Revenue | |
= | (51.456 | + | 180.497) | / | 211.172 | |
= | 1.10 |
3. Altman Z-Score.
Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
The zones of discrimination were as such:
When Z-Score is less than 1.81, it is in Distress Zones.
When Z-Score is greater than 2.99, it is in Safe Zones.
When Z-Score is between 1.81 and 2.99, it is in Grey Zones.
Xencor has a Z-score of 0.31, indicating it is in Distress Zones. This implies bankrupcy possibility in the next two years.
Warning Sign:
Altman Z-score of 0.31 is in distress zone. This implies bankruptcy possibility in the next two years.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Xencor (NAS:XNCR) Financial Strength Explanation
The rank is rated on a scale of 1 to 10. A higher score indicates a stronger financial position, with companies rated 7 or above considered financially stable and unlikely to face distress. Conversely, a score of 3 or below suggests potential financial difficulties, indicating a higher risk of distress.
Xencor has the Financial Strength Rank of 6.
Thank you for viewing the detailed overview of Xencor's Financial Strength provided by GuruFocus.com. Please click on the following links to see related term pages.
Nancy Valente | director | C/O MYOVANT SCIENCES INC., 2000 SIERRA POINT PARKWAY, 9TH FLOOR, BRISBANE CA 94005 |
Celia Eckert | officer: VP, GENERAL COUNSEL | C/O XENCOR, INC., 111 WEST LEMON AVENUE, MONROVIA CA 91016 |
John R Desjarlais | officer: SR. VICE PRESIDENT & CSO | C/O XENCOR, INC., 111 WEST LEMON AVENUE, MONROVIA CA 91016 |
Bassil I Dahiyat | director, officer: PRESIDENT & CEO | C/O XENCOR, INC., 111 WEST LEMON AVENUE, MONROVIA CA 91016 |
Alan Bruce Montgomery | director | 1111 MAIN STREET, SUITE 660, VANCOUVER WA 98660 |
Richard J Ranieri | director | 3005 FIRST AVE, SEATTLE WA 98121 |
Ellen Feigal | director | C/O XENCOR INC., 111 WEST LEMON AVENUE, MONROVIA CA 91016 |
Dagmar Rosa-bjorkeson | director | C/O BAXALTA INCORPORATED, 1200 LAKESIDE DRIVE, BANNOCKBURN IL 60015 |
Kevin Charles Gorman | director | 12790 EL CAMINO REAL, SAN DIEGO CA 92130 |
Kurt A Gustafson | director | 11388 SORRENTO VALLEY ROAD, SAN DIEGO CA 92121 |
John J Kuch | officer: SR. VICE PRESIDENT & CFO | C/O XENCOR, INC., 111 WEST LEMON AVENUE, MONROVIA CA 91016 |
Barbara Klencke | director | C/O SIERRA ONCOLOGY, INC., 1820 GATEWAY DRIVE, SUITE 110, SAN MATEO CA 94404 |
Allen Yang | officer: SR. VICE PRESIDENT & CMO | C/O XENCOR INC., 111 WEST LEMON AVENUE, MONROVIA CA 91016 |
Yujiro S Hata | director | C/O XENCOR, INC., 111 WEST LEMON AVENUE, MONROVIA CA 91016 |
Stafford John S Iii | 10 percent owner | 230 SOUTH LASALLE STREET 400, CHICAGO IL 60604 |
From GuruFocus
By GuruFocus Research • 03-07-2024
By GuruFocus News • 02-27-2025
By GuruFocus Research • 02-28-2024
By Business Wire • 09-06-2024
By GuruFocus News • 02-27-2025
By Business Wire • 05-09-2024
By Business Wire • 02-28-2024
By Business Wire • 10-04-2024
By GuruFocus News • 02-28-2025
By GuruFocus News • 11-13-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.